Science 37 Holdings, Inc.

NasdaqCM:SNCE Rapporto sulle azioni

Cap. di mercato: US$34.7m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Science 37 Holdings Salute del bilancio

Salute finanziaria criteri di controllo 5/6

Science 37 Holdings has a total shareholder equity of $51.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $75.7M and $24.0M respectively.

Informazioni chiave

0%

Rapporto debito/patrimonio netto

US$0

Debito

Indice di copertura degli interessin/a
ContantiUS$56.41m
Patrimonio nettoUS$51.74m
Totale passivitàUS$23.98m
Totale attivitàUS$75.73m

Aggiornamenti recenti sulla salute finanziaria

Science 37 Holdings (NASDAQ:SNCE) Is In A Good Position To Deliver On Growth Plans

Apr 11
Science 37 Holdings (NASDAQ:SNCE) Is In A Good Position To Deliver On Growth Plans

We Think Science 37 Holdings (NASDAQ:SNCE) Can Afford To Drive Business Growth

Nov 04
We Think Science 37 Holdings (NASDAQ:SNCE) Can Afford To Drive Business Growth

Recent updates

Science 37 Holdings, Inc. (NASDAQ:SNCE) Might Not Be As Mispriced As It Looks

Dec 18
Science 37 Holdings, Inc. (NASDAQ:SNCE) Might Not Be As Mispriced As It Looks

Investors Continue Waiting On Sidelines For Science 37 Holdings, Inc. (NASDAQ:SNCE)

Apr 17
Investors Continue Waiting On Sidelines For Science 37 Holdings, Inc. (NASDAQ:SNCE)

Science 37, Syapse team for faster patient enrollment in cancer trials

Aug 18

Science 37 reports Q2 mixed earnings; narrows FY22 guidance

Aug 11

Results: Science 37 Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

May 13
Results: Science 37 Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Science 37 Holdings (NASDAQ:SNCE) Is In A Good Position To Deliver On Growth Plans

Apr 11
Science 37 Holdings (NASDAQ:SNCE) Is In A Good Position To Deliver On Growth Plans

Science 37: Pioneering Decentralized Clinical Trials

Jan 02

We Think Science 37 Holdings (NASDAQ:SNCE) Can Afford To Drive Business Growth

Nov 04
We Think Science 37 Holdings (NASDAQ:SNCE) Can Afford To Drive Business Growth

Analisi della posizione finanziaria

Passività a breve termine: SNCE's short term assets ($75.5M) exceed its short term liabilities ($18.1M).

Passività a lungo termine: SNCE's short term assets ($75.5M) exceed its long term liabilities ($5.9M).


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: SNCE is debt free.

Riduzione del debito: SNCE has not had any debt for past 5 years.


Bilancio


Analisi della pista di contanti

Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.

Pista di liquidità stabile: SNCE has less than a year of cash runway based on its current free cash flow.

Previsione Cash Runway: SNCE has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 36.9% each year.


Scoprire le aziende sane